Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 12Lymphoid 10Classical hematology 10Plasma cell 7Other neoplasm 5Myeloid 3Dermatologic 3Thoracic 1Breast 1

Conditions

Breast Neoplasms 7Anemia 6Multiple Myeloma 2Lymphoma 2Small Cell Lung Carcinoma 1Red-Cell Aplasia, Pure 1Prostatic Neoplasms 1Precancerous Conditions 1Ovarian Neoplasms 1Neoplasms, Plasma Cell 1Neoplasms 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Lung Neoplasms 1Leukemia 1Fatigue 1Esophageal Neoplasms 1Drug-Related Side Effects and Adverse Reactions 1

Interventions

Cyclophosphamide 4Flow Cytometry 3Surveys and Questionnaires 2Radiotherapy 2Peripheral Blood Stem Cell Transplantation 2Methylprednisolone 2Methods 2Melphalan 2Immunologic Techniques 2Filgrastim 2Data Collection 2Blood Specimen Collection 2Azacitidine 2Alemtuzumab 2tanespimycin 1sargramostim 1ruxolitinib 1rucaparib 1ribociclib 1pembrolizumab 1motexafin gadolinium 1liposomal doxorubicin 1fludarabine phosphate 1flt3 ligand protein 1dexamethasone acetate 1dexamethasone 21-phosphate 1cc-486 1bosutinib 1aldesleukin 1abiraterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Epoetin Alfa × Breast × Clear all
NCT00003600 2016-07-13

Epoetin Alfa in Treating Anemia in Patients Who Are Receiving Chemotherapy

Alliance for Clinical Trials in Oncology

Phase 3 Completed
344 enrolled
BreastClassical hematologyLymphoidMyeloidOther hematologic neoplasmOther neoplasmPlasma cellThoracic

Anemia, Breast Neoplasms, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Myeloproliferative Disorders, Precancerous Conditions, Neoplasms, Plasma Cell, Drug-Related Side Effects and Adverse Reactions

Data powered by HemOnc (CC BY 4.0) Colophon âš¡